In-hospital outcomes of percutaneous coronary intervention (PCI) patients with different medical funds: an analysis

Tirawit Hongsakul1, Suppavit Chumsantivut2, Sukanya Siriyotha3

  • 1Division of Cardiovascular Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Open Heart
|February 16, 2026
PubMed

Insights

Healthcare funding in Thailand impacts percutaneous coronary intervention (PCI) outcomes. Patients under the Government Service Scheme (GS) had better results than those in the Universal Health Coverage (UC) or Social Security Scheme (SS).

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Health Economics

Background:

  • Limited data exists on percutaneous coronary intervention (PCI) outcomes across different healthcare funding systems in Thailand.
  • Understanding these disparities is crucial for improving patient care and health policy.

Purpose of the Study:

  • To investigate the association between in-hospital clinical outcomes of patients undergoing PCI and their respective healthcare funding schemes in Thailand.
  • To identify potential disparities in care based on insurance type.

Main Methods:

  • Utilized data from the Thai PCI registry, a multicenter prospective national registry (May 2018 - August 2020).
  • Analyzed clinical characteristics, management, and in-hospital outcomes of 22,741 patients across four funding groups: UC, GS, SS, and other.
  • Adjusted for baseline characteristics and management strategies to compare outcomes.

Main Results:

  • Patients in the Social Security Service Scheme (SS) and Universal Health Coverage Scheme (UC) had significantly higher in-hospital Major Adverse Cardiovascular Events (MACE) compared to the Government Service Scheme (GS).
  • Post-procedural myocardial infarction rates were elevated across all funding groups.
  • No statistically significant differences were observed in all-cause death or cerebrovascular accident/stroke rates between groups.

Conclusions:

  • Thai healthcare funding policies are significantly associated with disparities in in-hospital outcomes following PCI.
  • The Government Service Scheme (GS) was linked to superior clinical outcomes compared to other funding schemes.
  • Policy adjustments are needed to mitigate healthcare disparities and enhance patient outcomes in PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
325
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
380